搜尋
Brainstorm Cell Therapeutics Inc
BCLI添加自選
1.170USD
0.0000.00%
收盤 07/02, 13:00（美東）報價延遲15分鐘
9.26M總市值
虧損本益比TTM
關於 Brainstorm Cell Therapeutics Inc 公司
BrainStorm Cell Therapeutics Inc. 是一家自體成人幹細胞療法開發商，用於治療衰弱性神經退行性疾病。神經退行性疾病包括肌萎縮側索硬化症 (ALS)、進行性多發性硬化症 (PMS)、阿爾茨海默病 (AD) 等。該公司從事 NurOwn 技術平臺的臨牀開發和商業化，該平臺用於生產自體間充質幹細胞-神經營養因子 (MSC-NTF) 細胞。NurOwn 利用細胞培養方法誘導自體骨髓衍生的 MSC 分泌高水平 NTF，調節神經炎症和神經退行性疾病過程，促進神經元存活並改善神經功能。自體 MSC-NTF 細胞用於治療 ALS。該公司已完成 ALS 的 III 期試驗。其全資子公司 BrainStorm Cell Therapeutics Ltd. 擁有將 NurOwn 技術商業化的獨家權利。
Brainstorm Cell Therapeutics Inc簡介
公司代碼BCLI
公司名稱Brainstorm Cell Therapeutics Inc
上市日期May 28, 2003
CEOMr. Chaim Lebovits
員工數量27
證券類型Ordinary Share
年結日May 28
公司地址1325 Avenue Of Americas
城市NEW YORK
上市交易所US 'Other OTC' and Grey Market
國家United States of America
郵編10019
電話12014880460
網址https://brainstorm-cell.com/
公司代碼BCLI
上市日期May 28, 2003
CEOMr. Chaim Lebovits
Brainstorm Cell Therapeutics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Uri Yablonka
Mr. Uri Yablonka
Director, Executive Vice President, Chief Business Officer, Secretary
Director, Executive Vice President, Chief Business Officer, Secretary
68.46K
--
Dr. Hartoun Hartounian, Ph.D.
Dr. Hartoun Hartounian, Ph.D.
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
52.00K
--
Ms. Alla Patlis, CPA
Ms. Alla Patlis, CPA
Interim Chief Financial Officer, Controller
Interim Chief Financial Officer, Controller
44.35K
+2.07%
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
Director
Director
44.15K
--
Dr. Irit Arbel, Ph.D.
Dr. Irit Arbel, Ph.D.
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
41.05K
--
Mr. Nir Naor, CPA
Mr. Nir Naor, CPA
Independent Director
Independent Director
31.47K
+12.18%
Dr. Ibrahim B. (Bob) Dagher, M.D.
Dr. Ibrahim B. (Bob) Dagher, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Prof. Jacob A. Frenkel, Ph.D.
Prof. Jacob A. Frenkel, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Menghisteab (Menghis) Bairu, M.D.
Dr. Menghisteab (Menghis) Bairu, M.D.
Independent Director
Independent Director
--
--
Dr. Anthony John (Tony) Polverino, Ph.D.
Dr. Anthony John (Tony) Polverino, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Uri Yablonka
Mr. Uri Yablonka
Director, Executive Vice President, Chief Business Officer, Secretary
Director, Executive Vice President, Chief Business Officer, Secretary
68.46K
--
Dr. Hartoun Hartounian, Ph.D.
Dr. Hartoun Hartounian, Ph.D.
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
52.00K
--
Ms. Alla Patlis, CPA
Ms. Alla Patlis, CPA
Interim Chief Financial Officer, Controller
Interim Chief Financial Officer, Controller
44.35K
+2.07%
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
Director
Director
44.15K
--
Dr. Irit Arbel, Ph.D.
Dr. Irit Arbel, Ph.D.
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
41.05K
--
Mr. Nir Naor, CPA
Mr. Nir Naor, CPA
Independent Director
Independent Director
31.47K
+12.18%
常見問題
Brainstorm Cell Therapeutics Inc的前五大股東是誰？
Brainstorm Cell Therapeutics Inc的前五大股東如下：Mr. Uri Yablonka
有多少機構持有Brainstorm Cell Therapeutics Inc(BCLI)的股份？
截至2026Q1，共有77家機構持有Brainstorm Cell Therapeutics Inc的股份，合計持有的股份價值約為400.00，占公司總股份的0.01% 。與2025Q4相比，機構持股有所增加，增幅為-1195352.00。